Protocol for Rapid Drug Profiling of Patient-Derived Tumor-On-Chip Models

Authors:
  • CHClara Helal
    Clara Helal
  • AVAna Vazquez
    Ana Vazquez
  • JJJuliette Jin
    Juliette Jin
  • LDLéna Domalain
    Léna Domalain
  • NSNiccolo Schintu
    Niccolo Schintu
  • MSMaxime Simon
    Maxime Simon
  • MPMaria Carla Parrini
    Maria Carla Parrini
  • SDStephanie Descroix
    Stephanie Descroix

Abstract
Rapid drug sensitivity profiling from limited numbers of cancer cells remains challenging with the current models. Here, we present a Tumor-on-Chip protocol optimized for functional drug sensitivity profiling within 4 days, including a custom chip requiring minimal biopsy material. We describe tissue dissociation, tumor cell isolation, chip preparation, drug exposure, image acquisition, and data analysis for PDX-derived tumors, surgical resections, and biopsies. The protocol enables discrimination of drug-sensitive and resistant tumor profiles and provides a platform for patient-specific treatment testing.For complete details on the use and execution of this protocol, please refer to Helal et al.1